Rapid-Test Kit for Cardiac Troponin I: A Reliable Enzyme-Linked-Immuno-Substrate-Assay-Based Biosensor for Daily-Use Naked-Eye Detection and Pharmacokinetic Studies for Myocardial Infarction in Cardiovascular Disease.
Yu-Fang HsiehKuan-Jiuh LinPublished in: ACS pharmacology & translational science (2024)
Myocardial infarction (MI) is a severe cardiovascular event that can lead to death. Cardiac troponin I (cTnI) is an MI biomarker in the circulation system; however, methods for detecting cTnI protein require substantial time, tedious operations, an expensive reader for translating signals, and a lot of reagents. This study aims to create a cTnI protein test kit with results easily distinguished by color differences, explicitly focusing on the resolution between different concentrations that eyes can discern. These results will aid in creating a commercial, portable, convenient, daily-use rapid-test kit. This study proposes a cTnI biosensor that the naked eye can perceive, performs diagnoses based on pattern color, does not require a reader machine, is easy to operate, and is portable. Our device shortens diagnosis time, has a 0.32-200 ng/mL quantitative analysis range in the human serum matrix, achieves a 0.32 ng/mL limit of detection, and exhibits many advantages compared to a traditional cTnI ELISA plate.
Keyphrases
- loop mediated isothermal amplification
- cardiovascular disease
- label free
- heart failure
- gold nanoparticles
- left ventricular
- type diabetes
- optical coherence tomography
- quantum dots
- deep learning
- small molecule
- binding protein
- early onset
- coronary artery disease
- cardiovascular risk factors
- single cell
- cardiovascular events
- drug induced
- structural basis